XP (BUE:XP) Research & Development: ARS0.00 Mil (TTM As of Mar. 2026)


What is XP Research & Development?

XP BUE:XP 71 Research & Development is ARS0.00 Mil as of Mar. 2026. GuruFocus rates BUE:XP with a GF Score™ of 71/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. XP's Research & Development for the three months ended in Mar. 2026 was ARS0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ARS0.00 Mil.

XP  (BUE:XP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

XP Research & Development Related Terms

XP Research & Development Historical Data

* Premium members only.

The historical data trend for XP's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XP Research & Development Chart

XP Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XP Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XP Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ARS0.00 Mil mean?
XP (BUE:XP) has a Research & Development of ARS0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on XP and its competitors.
Is XP's Research & Development too high?
XP's current Research & Development is ARS0.00 Mil. Overall, XP has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does XP's Research & Development compare to SNEX and FIGR?
XP's Research & Development of ARS0.00 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on XP and its competitors. XP's current Research & Development is ARS0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XP stock overvalued right now?
XP (BUE:XP) has a current Research & Development of ARS0.00 Mil. The current Research & Development is ARS0.00 Mil. XP's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For XP (BUE:XP), the current Research & Development is ARS0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XP Business Description

Address 20, Genesis Close, George Town, Vila Olimpia, Grand Cayman, CYM, KY-1-1208
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.